Csequence is proud to announce the first part of our virtual expert panel series on the use of cannabis in fighting cancer.  In July we heard from physicians who discussed their views on the topic, the data they have seen and the trials they are working on. This discussion featured four opinion-leading physicians sharing their view of cannabis as medicine applied as a therapeutic as well as a supportive care treatment for cancer.

This panel covers a variety of topics including:

  • What we know to be true about the use of cannabis in cancer: treatment vs. supportive care
  • What data currently exists regarding the use of cannabis in the treatment of cancer
  • How good is the data currently available
  • What advice physicians give patients who are currently looking to supplement their treatment with cannabis

Csequence is a sales enablement firm focused on advancing the medicinal use of cannabis.  Our events serve at the heart of our mission to bridge quality research and effective use of medical cannabis.  We bring healthcare providers, patients, advocates, manufacturers, and regulators together with the purpose of creating a venue where ideas, data, information, and insight can be shared for the betterment of the community.

We are grateful for our sponsors: Reckner Healthcare, Black CannaBusiness Magazine, and Pineapple Ventures, Inc.

 

mm

Author Laura Smith

Laura is Managing Principal and lead of the Patient Centered Care work at Csequence. Laura brings extensive knowledge of the pharmaceutical industry and leads patient focused care at Csequence. Laura’s professional experience includes over 20 years in various roles within the healthcare industry as well as training in the intentional use of plant medicine, a background in community health education and is a grief recovery specialist. She has a unique educational background with an MBA from Yale University coupled with a MA in Spiritual Psychology from the University of Santa Monica.

More posts by Laura Smith